Coronado Biosciences Inc (CNDO) Return on Equity ROE from the fourth quarter 2014 to fourth quarter and annually, average high and low, overall ranking from Dec 31 2014 to - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Coronado Biosciences Inc  (CNDO)

Coronado Biosciences Inc's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Coronado Biosciences Inc in the fourth quarter 2014?
Coronado Biosciences Inc achieved a return on average equity (ROE) of 72.09 % in its fourth quarter 2014, this is above CNDO's average return on equity of 0%.
Coronado Biosciences Inc shareholder's equity over the 12 months ending in its fourth quarter 2014 are valued at $38 million

ROE has advanced compared to -48.22% in the fourth quarter 2013, due to net income growth.

Within the Major Pharmaceutical Preparations industry Coronado Biosciences Inc achieved the highest return on equity. While the total ranking for ROE unchanged, relative to the fourth quarter 2013 at no. .

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Dec 31 2014)
IV. Quarter		 (Dec 31 2013)
IV. Quarter


Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions 27 -10 0 0 0
Return On Equity (TTM) 72.09 % -48.22 % - - -
CNDO's Total Ranking # # # # #
Equity (TTM) in Millions 71 81 0 0 0
Seq. Equity Change -13.23 % - - - -
Seq. Net Income Change - - - - -

Back to CNDO Management Effectiveness >> CNDO's 5 Years Annual ROE >> Compare CNDO ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





CNDO Annual Return On Equity (Dec 31 2014)
2014		 (Dec 31 2013)
2013


Total Equity in Millions 71 81 0 0 0
Y / Y Equity Change -13.23 % - - - -
Net Income in Millions -20 -37 0 0 0
Y / Y Net Income Change - - - - -
Return On Equity -28.91 % -45.72 % - - -

Back to CNDO Management Effectiveness >> CNDO's 5 Years Annual ROE >> Compare CNDO ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CNDO's' Return on Equity at Yahoo Finance
CNDO's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CNDO's Competitors
Subscribers only: Roe for Coronado Biosciences Inc's Suppliers
Subscribers only: Return On Equity for CNDO's Customers




Companies with similar Return On Equity at Dec 31 2014, within Healthcare Sector ROE
Tuhura Biosciences Inc   160.48 %
Brainstorm Cell Therapeutics inc   136.80 %
Viskase Holdings inc   124.88 %
Agile Therapeutics Inc  115.22 %
Earth Science Tech Inc   115.12 %
Lumos Pharma Inc   96.45 %
Gilead Sciences Inc   80.65 %
Bioage Labs Inc   75.79 %
Sunwin Stevia International Inc.  62.05 %
Enanta Pharmaceuticals Inc  59.29 %
Idexx Laboratories Inc  55.46 %
Assertio Holdings inc   54.47 %
Amag Pharmaceuticals inc   52.19 %
Encompass Health Corporation  50.08 %
Pacific Health Care Organization Inc  49.86 %
Diversicare Healthcare Services Inc   49.78 %
Fonar Corporation  49.57 %
Eyepoint Inc   49.23 %
Zoetis Inc   45.97 %
Vanda Pharmaceuticals Inc   43.94 %
Abbvie Inc   43.53 %
Edwards Lifesciences Corporation  43.31 %
Astrotech Corp  41.53 %
Supernus Pharmaceuticals inc   41.31 %
Scientific Industries Inc   39.93 %
Mettler toledo International Inc   39.79 %
Lannett Company Inc  39.60 %
Celgene Corp  36.99 %
Iridex Corp  35.96 %
China Biologic Products Holdings Inc   34.92 %

Date modified: 2026-09-08T15:08:24+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.